Niels Grabow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Niels Grabow has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Klaus-Peter Schmitz
Institute for ImplantTechnology and Biomaterials e.V. and Institute for Biomedical Engineering, Rostock University Medical Center, Rostock-Warnemuende , Germany
8 shared publications - Hüseyin Ince
Gebze Teknik Üniversitesi
4 shared publications Claus Harder
3 shared publications- Daniela Arbeiter
Institute for Biomedical Engineering, University Medical Center Rostock, Friedrich-Barnewitz-Straße 4, 18119 Rostock, Germany
3 shared publications - Michael Stiehm
Institute of ImplantTechnology and Biomaterials e.V., Rostock-Warnemünde, Germany
3 shared publications - Sylvia Pfensig
Institute for Implant- Technology and Biomaterials e.V., Friedrich-Barnewitz-Str. 4, Rostock- Warnemünde , Germany
3 shared publications
Latest Publications
- Open Access
- 7 September 2017
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 3 (2) , 603-606
Inflow mapping method for numerical flow simulations of OCT-based patient-specific vessels using CFD
Alteration of the flow characteristics in coronary vessels is correlated with coronary heart disease (CHD). In particular, wall shear stress (WSS) appears to be a hemody-namic key factor in the genesis of CHD. Since computational fluid dynamics (CFD) is a well-known method for the inves-tigation of WSS, it may be a valuable tool for the prediction of CHD. Latest imaging techniques, such as optical coher-ence tomography (OCT) in conjunction with angiography deliver precise 2D data sets of patient-specific vessel geome-try, which can be used for CFD analysis. Current CFD stud-ies utilize patient-specific geometries, but are lacking well defined physiologic inflow conditions.In this study, we present an inflow mapping method for patient-specific arterial vessels, which is capable of consider-ing the influence of bifurcations located proximal of the OCT-data set. At first, the patient-specific vessel was recon-structed. For this purpose the OCT-based vessel cross sec-tions were arranged along an angiographic based vessel pathway. Secondly, we simulated the flow field in a generic bifurcation model by means of CFD. Thereafter the flow field of a side branch was extracted and transferred (mapped) to the inlet of the patient-specific vessel.To evaluate the influence of the physiological inlet the WSS distribution of the same patient-specific vessel was calculated using an axial-symmetric inflow condition. Analy-sis of the simulation data yielded deviations of the WSS distribution in the proximal vessel segment. A bifurcation, located upstream of the relevant vessel segment strongly affects the flow in the OCT-based vessel reconstruction and has a strong influence on the results of the numerical analy-sis. Therefore, it is important to implement not only the pa-tient-specific geometry, but also an inlet boundary condition adapted to the upstream velocity distribution reflecting the actual proximal flow situation of the vessel.
- 7 September 2017
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 3 (2) , 603-606
Open AccessInflow mapping method for numerical flow simulations of OCT-based patient-specific vessels using CFD
Alteration of the flow characteristics in coronary vessels is correlated with coronary heart disease (CHD). In particular, wall shear stress (WSS) appears to be a hemody-namic key factor in the genesis of CHD. Since computational fluid dynamics (CFD) is a well-known method for the inves-tigation of WSS, it may be a valuable tool for the prediction of CHD. Latest imaging techniques, such as optical coher-ence tomography (OCT) in conjunction with angiography deliver precise 2D data sets of patient-specific vessel geome-try, which can be used for CFD analysis. Current CFD stud-ies utilize patient-specific geometries, but are lacking well defined physiologic inflow conditions.In this study, we present an inflow mapping method for patient-specific arterial vessels, which is capable of consider-ing the influence of bifurcations located proximal of the OCT-data set. At first, the patient-specific vessel was recon-structed. For this purpose the OCT-based vessel cross sec-tions were arranged along an angiographic based vessel pathway. Secondly, we simulated the flow field in a generic bifurcation model by means of CFD. Thereafter the flow field of a side branch was extracted and transferred (mapped) to the inlet of the patient-specific vessel.To evaluate the influence of the physiological inlet the WSS distribution of the same patient-specific vessel was calculated using an axial-symmetric inflow condition. Analy-sis of the simulation data yielded deviations of the WSS distribution in the proximal vessel segment. A bifurcation, located upstream of the relevant vessel segment strongly affects the flow in the OCT-based vessel reconstruction and has a strong influence on the results of the numerical analy-sis. Therefore, it is important to implement not only the pa-tient-specific geometry, but also an inlet boundary condition adapted to the upstream velocity distribution reflecting the actual proximal flow situation of the vessel.
- Open Access
- 7 September 2017
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 3 (2) , 139-142
Expansion characteristics of coronary stents in focal stenoses
The presented experimental in vitro approach was designed to assess the expansion behavior of stent systems in a resistant focal stenosis model with respect to a potential dog-boning effect. Five different stent systems (nominal diameter 3.0 mm) were investigated. The focal stenosis was simulated by a stainless steel tube (ID ≤ 1.20 mm). Stent expansion was performed using a proprietary test device consisting of a test chamber with 37 °C water, 2-axis laser scanner and a pressure controller.All stents could be properly expanded up to recommended maximum pressure (RBP). At nominal pressure (NP) maximum diameters ranged from 2.923 to 3.560 mm while at RBP the maximum diameters were 3.391 to 3.984 mm. Only minimal flaring of stent struts from the expanded balloon was observed. None of the stent systems failed under the extremely high stress at the edges of the focal stenosis.
- 7 September 2017
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 3 (2) , 139-142
Open AccessExpansion characteristics of coronary stents in focal stenoses
The presented experimental in vitro approach was designed to assess the expansion behavior of stent systems in a resistant focal stenosis model with respect to a potential dog-boning effect. Five different stent systems (nominal diameter 3.0 mm) were investigated. The focal stenosis was simulated by a stainless steel tube (ID ≤ 1.20 mm). Stent expansion was performed using a proprietary test device consisting of a test chamber with 37 °C water, 2-axis laser scanner and a pressure controller.All stents could be properly expanded up to recommended maximum pressure (RBP). At nominal pressure (NP) maximum diameters ranged from 2.923 to 3.560 mm while at RBP the maximum diameters were 3.391 to 3.984 mm. Only minimal flaring of stent struts from the expanded balloon was observed. None of the stent systems failed under the extremely high stress at the edges of the focal stenosis.
- Open Access
- 7 September 2017
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 3 (2) , 703-706
Cyclic stress-strain behavior of polymeric nonwoven structures for the use as artificial leaflet material for transcatheter heart valve prostheses
Xenogenic leaflet material, bovine and porcine pericardium, is widely used for the fabrication of surgically implanted and transcatheter heart valve prostheses. As a biological material, long term durability of pericardium is limited due to calcification, degeneration and homogeneity. Therefore, polymeric materials represent a promising approach for a next generation of artificial heart valve leaflets with improved durability. Within the current study we analyzed the mechanical performance of polymeric structures based on elastomeric materials. Polymeric cast films were prepared and nonwovens were manufactured in an electrospinning process. Analysis of cyclic stress-strain behavior was performed, using a universal testing machine. The uniaxial cyclic tensile experiments of the elastomeric samples yielded a non-linear elastic response due to viscoelastic behavior with hysteresis. Equilibrium of stress-strain curves was found after a specific number of cycles, for cast films and nonwovens, respectively. In conclusion, preconditioning was found obligatory for the evaluation of the mechanical performance of polymeric materials for the use as artificial leaflet material for heart valve prostheses.
- 7 September 2017
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 3 (2) , 703-706
Open AccessCyclic stress-strain behavior of polymeric nonwoven structures for the use as artificial leaflet material for transcatheter heart valve prostheses
Xenogenic leaflet material, bovine and porcine pericardium, is widely used for the fabrication of surgically implanted and transcatheter heart valve prostheses. As a biological material, long term durability of pericardium is limited due to calcification, degeneration and homogeneity. Therefore, polymeric materials represent a promising approach for a next generation of artificial heart valve leaflets with improved durability. Within the current study we analyzed the mechanical performance of polymeric structures based on elastomeric materials. Polymeric cast films were prepared and nonwovens were manufactured in an electrospinning process. Analysis of cyclic stress-strain behavior was performed, using a universal testing machine. The uniaxial cyclic tensile experiments of the elastomeric samples yielded a non-linear elastic response due to viscoelastic behavior with hysteresis. Equilibrium of stress-strain curves was found after a specific number of cycles, for cast films and nonwovens, respectively. In conclusion, preconditioning was found obligatory for the evaluation of the mechanical performance of polymeric materials for the use as artificial leaflet material for heart valve prostheses.
- Open Access
- 1 September 2017
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 3 (2) , 631-634
Assessment of heart valve performance by finite-element design studies of polymeric leaflet-structures
For the treatment of severe symptomatic aortic valve stenosis, minimally invasive heart valve prostheses are increasingly used, especially for elderly patients. The current generation of devices is based on xenogenic leaflet material, involving limitations with regard to calcification and durability. Artificial polymeric leaflet-structures re-present a promising approach for improvement of valve performance. Within the current work, finite-element ana-lysis (FEA) design studies of polymeric leaflet structures were conducted. Design of an unpressurized and axially-symmetric trileaflet heart valve was developed based on nine parameters. Physiological pressurization in FEA was specified, based on in vitro hydrodynamic testing of a commercially available heart valve prosthesis. Hyper-elastic constitutive law for polymeric leaflet material was implemented based on experimental stress strain curves resulting from uniaxial tensile and planar shear testing. As a result of FEA, time dependent leaflet deformation of the leaflet structure was calculated. Obtained leaflet dynamics were comparable to in vitro performance of the analyzed prosthesis. As a major design parameter, the lunula angle has demonstrated crucial influence on the performance of the polymeric leaflet structures. FEA represented a useful tool for design of improved polymeric leaflet structures for minimally invasive implantable heart valve prostheses.
- 1 September 2017
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 3 (2) , 631-634
Open AccessAssessment of heart valve performance by finite-element design studies of polymeric leaflet-structures
For the treatment of severe symptomatic aortic valve stenosis, minimally invasive heart valve prostheses are increasingly used, especially for elderly patients. The current generation of devices is based on xenogenic leaflet material, involving limitations with regard to calcification and durability. Artificial polymeric leaflet-structures re-present a promising approach for improvement of valve performance. Within the current work, finite-element ana-lysis (FEA) design studies of polymeric leaflet structures were conducted. Design of an unpressurized and axially-symmetric trileaflet heart valve was developed based on nine parameters. Physiological pressurization in FEA was specified, based on in vitro hydrodynamic testing of a commercially available heart valve prosthesis. Hyper-elastic constitutive law for polymeric leaflet material was implemented based on experimental stress strain curves resulting from uniaxial tensile and planar shear testing. As a result of FEA, time dependent leaflet deformation of the leaflet structure was calculated. Obtained leaflet dynamics were comparable to in vitro performance of the analyzed prosthesis. As a major design parameter, the lunula angle has demonstrated crucial influence on the performance of the polymeric leaflet structures. FEA represented a useful tool for design of improved polymeric leaflet structures for minimally invasive implantable heart valve prostheses.
- Open Access
- 1 September 2016
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 2 (1) , 297-300
Transient Euler-Lagrange/DEM simulation of stent thrombosis
Stent implantation is the treatment of choice for cardiovascular diseases. By introduction of biodegradable thick strut stents investigations of thrombosis formation is one focus of research. This study deals with a transient Euler-Lagrange/DEM approach to simulate the flow field, platelet movement and clotting. The recirculation zones prolong particle residence time. As a result, the vicinity of stent struts shown a particularly higher risk for stent thrombosis.
- 1 September 2016
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 2 (1) , 297-300
Open AccessTransient Euler-Lagrange/DEM simulation of stent thrombosis
Stent implantation is the treatment of choice for cardiovascular diseases. By introduction of biodegradable thick strut stents investigations of thrombosis formation is one focus of research. This study deals with a transient Euler-Lagrange/DEM approach to simulate the flow field, platelet movement and clotting. The recirculation zones prolong particle residence time. As a result, the vicinity of stent struts shown a particularly higher risk for stent thrombosis.
- Open Access
- 1 September 2016
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 2 (1) , 1-4
Synthesis and characterization of PIL/pNIPAAm hybrid hydrogels
In this study, varying amounts of NIPAAm and an ionic liquid (IL), namely 1-vinyl-3-isopropylimidazolium bromide ([ViPrIm]+[Br]−), have been used to synthesize hybrid hydrogels by radical emulsion polymerization. Amounts of 70/30%, 50/50%, 30/70%, 15/85% and 5/95% (wt/wt) of PIL/pNIPAAm were used to produce hybrid hydrogels as well as the parental hydrogels. The adhesive strength was investigated and evaluated for mechanical characterization. Thermal properties of resulting hydrogels have been investigated using differential scanning calorimetry (DSC) in a default heating temperature range (heating rate 10 K min−1). The presence of poly ionic liquids (PIL) in the polymer matrix leads to a moved LCST (lower critical solution temperature) to a higher temperature range for certain hybrid hydrogels PIL/pNIPAAm. While pNIPAAm exhibits an LCST at 33.9 ± 0.3°C, PIL/pNIPAAm 5/95% and PIL/pNIPAAm 15/85% were found to have LCSTs at 37.6 ± 0.9°C and 52 ± 2°C, respectively. This could be used for controlled drug release that goes along with increasing body temperature in response to an implantation caused infection
- 1 September 2016
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 2 (1) , 1-4
Open AccessSynthesis and characterization of PIL/pNIPAAm hybrid hydrogels
In this study, varying amounts of NIPAAm and an ionic liquid (IL), namely 1-vinyl-3-isopropylimidazolium bromide ([ViPrIm]+[Br]−), have been used to synthesize hybrid hydrogels by radical emulsion polymerization. Amounts of 70/30%, 50/50%, 30/70%, 15/85% and 5/95% (wt/wt) of PIL/pNIPAAm were used to produce hybrid hydrogels as well as the parental hydrogels. The adhesive strength was investigated and evaluated for mechanical characterization. Thermal properties of resulting hydrogels have been investigated using differential scanning calorimetry (DSC) in a default heating temperature range (heating rate 10 K min−1). The presence of poly ionic liquids (PIL) in the polymer matrix leads to a moved LCST (lower critical solution temperature) to a higher temperature range for certain hybrid hydrogels PIL/pNIPAAm. While pNIPAAm exhibits an LCST at 33.9 ± 0.3°C, PIL/pNIPAAm 5/95% and PIL/pNIPAAm 15/85% were found to have LCSTs at 37.6 ± 0.9°C and 52 ± 2°C, respectively. This could be used for controlled drug release that goes along with increasing body temperature in response to an implantation caused infection
- Open Access
- 1 September 2016
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 2 (1) , 359-362
Investigation of the pressure gradient of embolic protection devices
To avoid debris coming to the cerebral vessels during carotid artery stenting, embolic protection devices (EPD) are placed in front of the lesion. To evaluate their influence on the antegrade blood flow a test setup with a silicone tube simulating the internal carotid artery is realized. The pressure gradient of five different EPD was measured while particles were brought into the circuit and were caught by the systems. Additionally the microscopic structure of the systems was observed to correlate the morphology and the pressure gradient. The FiberNet device had the lowest pressure gradient. It was the only system that consists of fibers contrary to the systems RX Accunet, Angioguard RX, FilterWireEZ and EmboshieldNAV that contain porous membranes
- 1 September 2016
- Published by Walter de Gruyter GmbH in Current Directions in Biomedical Engineering
- Vol. 2 (1) , 359-362
Open AccessInvestigation of the pressure gradient of embolic protection devices
To avoid debris coming to the cerebral vessels during carotid artery stenting, embolic protection devices (EPD) are placed in front of the lesion. To evaluate their influence on the antegrade blood flow a test setup with a silicone tube simulating the internal carotid artery is realized. The pressure gradient of five different EPD was measured while particles were brought into the circuit and were caught by the systems. Additionally the microscopic structure of the systems was observed to correlate the morphology and the pressure gradient. The FiberNet device had the lowest pressure gradient. It was the only system that consists of fibers contrary to the systems RX Accunet, Angioguard RX, FilterWireEZ and EmboshieldNAV that contain porous membranes
- 1 January 2015
- Published by Walter de Gruyter GmbH in BioNanoMaterials
- Vol. 16 (4) , 285-299
Direct sprayed endothelialization, basement membrane and cell junction development on biological and artificial products are highly substrate-dependent and require optimized biofunctionalization
Background: Optimizing endothelialization of medical implants requires deep mechanistic insight into cellular adhesion, cell junction and physiological basement membrane development at the endothelial cell-to-scaffold substrate interface. Methods and results: We employed and standardized endothelial cells and fibrin hydrogel for simultaneous cell-plus-fibrin (EC-Fib) spray application using the Maslanka® spray pen. Quality assessment illustrated excellent structural integrity of EC-Fib. Acellular SynerGraft® showed improved intimal endothelial recellularization after short-term physical and chemical preconditionings including dry-freezing, sodium desoxycholate, Triton-X, acetic acid and collagenase treatments. Artificial substrates poly-L-lactic acid (PLLA), and polyamide-6 (PA-6) were tested regarding their mechanical appropriateness, revealed complete endothelialization following EC-Fib application and showed partially physiological basement membrane development. Additional laminin 1 biofunctionalization on PA-6 moderately enhanced basement membrane gene and protein expression. However, scanning electron microscopy, immunohistology and PCR analyses underlined immature endothelialization, basement membrane and cell junction development on all substrates with clear substrate-dependent differences. Conclusions: Direct sprayed endothelialization outlined the necessity for preconditioning acellular SynerGraft® prostheses for adequate recellularization. Laminin 1 biofunctionalization could slightly improve endothelialization of PA-6 substrates whereas physiological organization of the microenvironment remained immature and seemed highly substrate dependent.
- 1 January 2015
- Published by Walter de Gruyter GmbH in BioNanoMaterials
- Vol. 16 (4) , 285-299
Direct sprayed endothelialization, basement membrane and cell junction development on biological and artificial products are highly substrate-dependent and require optimized biofunctionalization
Background: Optimizing endothelialization of medical implants requires deep mechanistic insight into cellular adhesion, cell junction and physiological basement membrane development at the endothelial cell-to-scaffold substrate interface. Methods and results: We employed and standardized endothelial cells and fibrin hydrogel for simultaneous cell-plus-fibrin (EC-Fib) spray application using the Maslanka® spray pen. Quality assessment illustrated excellent structural integrity of EC-Fib. Acellular SynerGraft® showed improved intimal endothelial recellularization after short-term physical and chemical preconditionings including dry-freezing, sodium desoxycholate, Triton-X, acetic acid and collagenase treatments. Artificial substrates poly-L-lactic acid (PLLA), and polyamide-6 (PA-6) were tested regarding their mechanical appropriateness, revealed complete endothelialization following EC-Fib application and showed partially physiological basement membrane development. Additional laminin 1 biofunctionalization on PA-6 moderately enhanced basement membrane gene and protein expression. However, scanning electron microscopy, immunohistology and PCR analyses underlined immature endothelialization, basement membrane and cell junction development on all substrates with clear substrate-dependent differences. Conclusions: Direct sprayed endothelialization outlined the necessity for preconditioning acellular SynerGraft® prostheses for adequate recellularization. Laminin 1 biofunctionalization could slightly improve endothelialization of PA-6 substrates whereas physiological organization of the microenvironment remained immature and seemed highly substrate dependent.
- 1 January 2013
- Vol. 14 (1) , 76-90
Advances in coronary stent technology--active drug-loaded stent surfaces for prevention of restenosis and improvement of biocompatibility.
Beyond their originally sole mechanical function, current drug-eluting stents (DES) implement the concept of local drug delivery for the re-opening of stenotic arterial vessels, and for prevention of in-stent restenosis as one of the major limitations of conventional bare metal stents (BMS). Current DES consist of a permanent metallic stent platform and an active agent being released from a drug-incorporated polymer coating or a porous stent surface. Although DES have impressively demonstrated their capability of reducing in-stent restenosis, their safety remains under debate due to potential risks, such as delayed healing, late thrombosis and hypersensitivity demanding further development. Current advancements in the stent design address the stent platform, the pharmacologically active substance and/or the drug carrier. For instance, novel biocompatible absorbable stent platforms and drug carriers are developed and novel drugs with a differential effect on vascular endothelial and smooth muscle cells, providing efficient inhibition of muscle cells without altering the endothelial cell function, are identified. Moreover, biofunctionalization of the stent's surface with capture molecules for endothelial progenitor cells are under investigation in order to achieve an in situ endothelialization of the implant. In this context, this review paper discusses the current advances in coronary stent technology with a special focus on novel stent platforms, drugs and stent coatings for the prevention of restenosis and improvement of biocompatibility.
- 1 January 2013
- Vol. 14 (1) , 76-90
Advances in coronary stent technology--active drug-loaded stent surfaces for prevention of restenosis and improvement of biocompatibility.
Beyond their originally sole mechanical function, current drug-eluting stents (DES) implement the concept of local drug delivery for the re-opening of stenotic arterial vessels, and for prevention of in-stent restenosis as one of the major limitations of conventional bare metal stents (BMS). Current DES consist of a permanent metallic stent platform and an active agent being released from a drug-incorporated polymer coating or a porous stent surface. Although DES have impressively demonstrated their capability of reducing in-stent restenosis, their safety remains under debate due to potential risks, such as delayed healing, late thrombosis and hypersensitivity demanding further development. Current advancements in the stent design address the stent platform, the pharmacologically active substance and/or the drug carrier. For instance, novel biocompatible absorbable stent platforms and drug carriers are developed and novel drugs with a differential effect on vascular endothelial and smooth muscle cells, providing efficient inhibition of muscle cells without altering the endothelial cell function, are identified. Moreover, biofunctionalization of the stent's surface with capture molecules for endothelial progenitor cells are under investigation in order to achieve an in situ endothelialization of the implant. In this context, this review paper discusses the current advances in coronary stent technology with a special focus on novel stent platforms, drugs and stent coatings for the prevention of restenosis and improvement of biocompatibility.